Free Trial
NYSEAMERICAN:VNRX

VolitionRX (VNRX) Stock Price, News & Analysis

VolitionRX logo
$0.64 0.00 (-0.19%)
As of 08/1/2025 04:10 PM Eastern

About VolitionRX Stock (NYSEAMERICAN:VNRX)

Key Stats

Today's Range
$0.60
$0.66
50-Day Range
$0.48
$0.92
52-Week Range
$0.40
$0.94
Volume
137,752 shs
Average Volume
143,513 shs
Market Capitalization
$66.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

VolitionRX Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

VNRX MarketRank™: 

VolitionRX scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for VolitionRX.

  • Earnings Growth

    Earnings for VolitionRX are expected to grow in the coming year, from ($0.50) to ($0.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of VolitionRX is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of VolitionRX is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about VolitionRX's valuation and earnings.
  • Percentage of Shares Shorted

    0.35% of the outstanding shares of VolitionRX have been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently decreased by 53.77%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    VolitionRX does not currently pay a dividend.

  • Dividend Growth

    VolitionRX does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.35% of the outstanding shares of VolitionRX have been sold short.
  • Short Interest Ratio / Days to Cover

    VolitionRX has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in VolitionRX has recently decreased by 53.77%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for VolitionRX this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for VNRX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, VolitionRX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.40% of the stock of VolitionRX is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.09% of the stock of VolitionRX is held by institutions.

  • Read more about VolitionRX's insider trading history.
Receive VNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VolitionRX and its competitors with MarketBeat's FREE daily newsletter.

VNRX Stock News Headlines

Q1 2025 VolitionRX Ltd Earnings Call Transcript
Is America’s Everything Bubble About to Burst?
On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushing America’s debt-to-GDP ratio to 175%. Top investors are warning of an epic bubble bursting soon. A free guide reveals how to shield your 401(k), savings, and portfolio before the collapse.
VolitionRX Q1 2025 Earnings Preview
See More Headlines

VNRX Stock Analysis - Frequently Asked Questions

VolitionRX's stock was trading at $0.58 at the start of the year. Since then, VNRX shares have increased by 10.3% and is now trading at $0.64.

VolitionRX Limited (NYSEAMERICAN:VNRX) posted its earnings results on Wednesday, November, 10th. The medical research company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.02. The medical research company had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.03 million.

Shares of VNRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VolitionRX investors own include Chesapeake Energy (CHKAQ), Bausch Health Cos (BHC), Avino Silver & Gold Mines (ASM), Exelixis (EXEL), T2 Biosystems (TTOO), Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX).

Company Calendar

Last Earnings
11/10/2021
Today
8/03/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:VNRX
Previous Symbol
NYSEMKT:VNRX
CIK
93314
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.56)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.97 million
Net Margins
-1,835.37%
Pretax Margin
-1,853.55%
Return on Equity
N/A
Return on Assets
-220.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.40
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$1.23 million
Price / Sales
54.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-2.29

Miscellaneous

Outstanding Shares
103,980,000
Free Float
93,168,000
Market Cap
$66.55 million
Optionable
Not Optionable
Beta
1.26
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSEAMERICAN:VNRX) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners